7096.T
Price:
$775
Market Cap:
$7.89B
StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
Industry
Biotechnology
IPO Date
Stock Exchange
JPX
Ticker
7096.T
According to StemCell Institute Inc.’s latest financial reports and current stock price. The company's current ROE is 9.23%. This represents a change of 303.63% compared to the average of 2.29% of the last 4 quarters.
The mean historical ROE of StemCell Institute Inc. over the last ten years is 11.32%. The current 9.23% ROE has changed -18.44% with respect to the historical average. Over the past ten years (40 quarters), 7096.T's ROE was at its highest in in the June 2024 quarter at 6.41%. The ROE was at its lowest in in the March 2023 quarter at 1.12%.
Average
11.32%
Median
10.08%
Minimum
4.72%
Maximum
22.00%
Discovering the peaks and valleys of StemCell Institute Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 35.55%
Maximum Annual ROE = 22.00%
Minimum Annual Increase = -78.56%
Minimum Annual ROE = 4.72%
| Year | ROE | Change |
|---|---|---|
| 2025 | 14.68% | 27.12% |
| 2024 | 11.55% | 34.06% |
| 2023 | 8.62% | 35.55% |
| 2022 | 6.36% | 34.74% |
| 2021 | 4.72% | -78.56% |
The current ROE of StemCell Institute Inc. (7096.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.62%
5-year avg
9.18%
10-year avg
11.32%
StemCell Institute Inc.’s ROE is less than Kohjin Bio Co., Ltd. (12.85%), greater than Chiome Bioscience Inc. (-62.16%), greater than ADR120S, Inc. (-133.55%), greater than Linical Co., Ltd. (-8.74%), greater than MEDINET Co., Ltd. (-31.14%), greater than K Pharma,Inc. (-40.16%), greater than OncoTherapy Science, Inc. (-90.96%), greater than BrightPath Biotherapeutics Co., Ltd. (-97.87%), greater than Noile-Immune Biotech Inc. (-15.03%), less than Mental Health Technologies Co.,Ltd. (24.92%),
| Company | ROE | Market cap |
|---|---|---|
| 12.85% | $7.96B | |
| -62.16% | $7.55B | |
| -133.55% | $7.44B | |
| -8.74% | $6.82B | |
| -31.14% | $8.21B | |
| -40.16% | $7.43B | |
| -90.96% | $7.11B | |
| -97.87% | $4.63B | |
| -15.03% | $6.97B | |
| 24.92% | $9.00B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like StemCell Institute Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like StemCell Institute Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is StemCell Institute Inc.'s ROE?
How is the ROE calculated for StemCell Institute Inc. (7096.T)?
What is the highest ROE for StemCell Institute Inc. (7096.T)?
What is the 3-year average ROE for StemCell Institute Inc. (7096.T)?
What is the 5-year average ROE for StemCell Institute Inc. (7096.T)?
How does the current ROE for StemCell Institute Inc. (7096.T) compare to its historical average?